These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24650454)

  • 21. Overexpression of long non-coding RNA NR_036575.1 contributes to the proliferation and migration of papillary thyroid cancer.
    Sun W; Lan X; Wang Z; Dong W; He L; Zhang T; Zhang H
    Med Oncol; 2016 Sep; 33(9):102. PubMed ID: 27510368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression profiling and functional analysis of microRNAs through stage I-III papillary thyroid carcinoma.
    Zhang J; Liu Y; Liu Z; Wang XM; Yin DT; Zheng LL; Zhang DY; Lu XB
    Int J Med Sci; 2013; 10(5):585-92. PubMed ID: 23533107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-181b-5p Facilitates Thyroid Cancer Growth via Targeting Programmed Cell Death 4.
    Geng X; Li Y; Sun Y; Cao L; Song Z
    Mol Biotechnol; 2024 May; 66(5):1154-1164. PubMed ID: 38253901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma.
    Qiu Z; Li H; Wang J; Sun C
    Oncol Rep; 2017 Nov; 38(5):2735-2740. PubMed ID: 29048684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Lin28A/let-7a/c-Myc Pathway in Growth and Malignant Behavior of Papillary Thyroid Carcinoma.
    Huang J; Lin H; Zhong M; Huang J; Sun S; Lin L; Chen Y
    Med Sci Monit; 2018 Dec; 24():8899-8909. PubMed ID: 30531691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PDGF-BB Enhances the Proliferation of Cells in Human Orbital Fibroblasts by Suppressing PDCD4 Expression Via Up-Regulation of microRNA-21.
    Lee JY; Yun M; Paik JS; Lee SB; Yang SW
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):908-13. PubMed ID: 26943153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum microRNA profiling to distinguish papillary thyroid cancer from benign thyroid masses.
    Graham ME; Hart RD; Douglas S; Makki FM; Pinto D; Butler AL; Bullock M; Rigby MH; Trites JR; Taylor SM; Singh R
    J Otolaryngol Head Neck Surg; 2015 Sep; 44(1):33. PubMed ID: 26341226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LGR5 is associated with tumor aggressiveness in papillary thyroid cancer.
    Michelotti G; Jiang X; Sosa JA; Diehl AM; Henderson BB
    Oncotarget; 2015 Oct; 6(33):34549-60. PubMed ID: 26416247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-182 targets CHL1 and controls tumor growth and invasion in papillary thyroid carcinoma.
    Zhu H; Fang J; Zhang J; Zhao Z; Liu L; Wang J; Xi Q; Gu M
    Biochem Biophys Res Commun; 2014 Jul; 450(1):857-62. PubMed ID: 24971532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative assessment of RASSF1A methylation as a putative molecular marker in papillary thyroid carcinoma.
    Kunstman JW; Korah R; Healy JM; Prasad M; Carling T
    Surgery; 2013 Dec; 154(6):1255-61; discussion 1261-2. PubMed ID: 24383114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. USP33 is a Biomarker of Disease Recurrence in Papillary Thyroid Carcinoma.
    Jia M; Guo Y; Lu X
    Cell Physiol Biochem; 2018; 45(5):2044-2053. PubMed ID: 29533940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RASSF10 is Epigenetically Inactivated and Suppresses Cell Proliferation and Induces Cell Apoptosis by Activating the p53 Signalling Pathway in Papillary Thyroid Carcinoma Cancer.
    Fan C; Wang W; Jin J; Yu Z; Xin X
    Cell Physiol Biochem; 2017; 41(3):1229-1239. PubMed ID: 28268222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactive role of miR-126 on VEGF-A and progression of papillary and undifferentiated thyroid carcinoma.
    Salajegheh A; Vosgha H; Rahman MA; Amin M; Smith RA; Lam AK
    Hum Pathol; 2016 May; 51():75-85. PubMed ID: 27067785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of lncRNA-ATB by Transforming Growth Factor β1 (TGF-β1) Promotes Migration and Invasion of Papillary Thyroid Carcinoma Cells.
    Cui M; Chang Y; Du W; Liu S; Qi J; Luo R; Luo S
    Med Sci Monit; 2018 Jul; 24():5152-5158. PubMed ID: 30042377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer.
    Lee JC; Zhao JT; Clifton-Bligh RJ; Gill A; Gundara JS; Ip JC; Glover A; Sywak MS; Delbridge LW; Robinson BG; Sidhu SB
    Cancer; 2013 Dec; 119(24):4358-65. PubMed ID: 24301304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PDLIM5 identified by label-free quantitative proteomics as a potential novel biomarker of papillary thyroid carcinoma.
    Wei X; Zhang Y; Yu S; Li S; Jiang W; Zhu Y; Xu Y; Yang C; Tian G; Mi J; Bergquist J; Zhao M; Song F
    Biochem Biophys Res Commun; 2018 May; 499(2):338-344. PubMed ID: 29574154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Landscape of Circular RNA Expression Profiles in Papillary Thyroid Carcinoma Based on RNA Sequencing.
    Lan X; Xu J; Chen C; Zheng C; Wang J; Cao J; Zhu X; Ge M
    Cell Physiol Biochem; 2018; 47(3):1122-1132. PubMed ID: 29847813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-204-5p suppresses cell proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma.
    Liu L; Wang J; Li X; Ma J; Shi C; Zhu H; Xi Q; Zhang J; Zhao X; Gu M
    Biochem Biophys Res Commun; 2015 Feb; 457(4):621-6. PubMed ID: 25603050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.
    Mitomo S; Maesawa C; Ogasawara S; Iwaya T; Shibazaki M; Yashima-Abo A; Kotani K; Oikawa H; Sakurai E; Izutsu N; Kato K; Komatsu H; Ikeda K; Wakabayashi G; Masuda T
    Cancer Sci; 2008 Feb; 99(2):280-6. PubMed ID: 18201269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.
    Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z
    Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.